Ashton Thomas Private Wealth LLC Increases Stock Position in Zoetis Inc. $ZTS

Ashton Thomas Private Wealth LLC raised its holdings in Zoetis Inc. (NYSE:ZTS) by 6.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,544 shares of the company’s stock after purchasing an additional 1,674 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Zoetis were worth $4,295,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Nova Wealth Management Inc. purchased a new stake in shares of Zoetis in the first quarter valued at about $25,000. 1248 Management LLC purchased a new position in shares of Zoetis during the first quarter valued at approximately $27,000. Saudi Central Bank purchased a new position in shares of Zoetis during the first quarter valued at approximately $29,000. REAP Financial Group LLC lifted its stake in shares of Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after buying an additional 131 shares during the period. Finally, Cornerstone Planning Group LLC lifted its stake in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock valued at $30,000 after buying an additional 88 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on ZTS. Piper Sandler upped their price objective on shares of Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Leerink Partners downgraded shares of Zoetis from an “outperform” rating to a “market perform” rating and reduced their price objective for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Argus reissued a “buy” rating and set a $190.00 price objective on shares of Zoetis in a research note on Tuesday, September 9th. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Finally, UBS Group cut their price target on shares of Zoetis from $165.00 to $158.00 and set a “neutral” rating on the stock in a research note on Monday, October 20th. Four investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $195.00.

Zoetis Stock Performance

NYSE:ZTS opened at $147.57 on Tuesday. The firm has a 50-day moving average of $148.08 and a two-hundred day moving average of $153.52. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock has a market cap of $65.40 billion, a P/E ratio of 25.40, a PEG ratio of 2.35 and a beta of 0.90. Zoetis Inc. has a 1-year low of $139.34 and a 1-year high of $184.40.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.14. The company had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The company’s revenue was up 4.2% on a year-over-year basis. During the same period last year, the firm earned $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is currently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.